Page last updated: 2024-08-23

bromocriptine and Invasiveness, Neoplasm

bromocriptine has been researched along with Invasiveness, Neoplasm in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19908 (34.78)18.7374
1990's5 (21.74)18.2507
2000's7 (30.43)29.6817
2010's1 (4.35)24.3611
2020's2 (8.70)2.80

Authors

AuthorsStudies
Oearsakul, T; Taweesomboonyat, C1
Chen, Y; Fang, Q; Gao, H; Gui, S; Guo, J; Li, C; Liu, C; Wang, J; Wang, Z; Xie, W; Zhang, Y; Zhao, P; Zhu, H1
Huang, HY; Hui, GZ; Tang, H; Wu, ZB; Zhai, W1
Ho, WL; Shen, CC; Yang, MY1
Delgrange, E; Jan, M; Perrin, G; Sassolas, G; Trouillas, J1
Gong, J; Wu, Z; Yu, C1
Su, ZP; Wu, JS; Wu, ZB; Zheng, WM; Zhong, M; Zhuge, QC1
Chang, RJ; Goodman, LA1
Coca, JM; Díaz de Tuesta, JI; Izquierdo, JM; San Emeterio, F1
Alfonso Collado, JI; Domínguez Ugidos, LJ; Martínez Subías, J; Sancho Serrano, E; Urpegui García, A; Vallés Varela, H1
Acikgoz, B; Oruckaptan, HH; Ozcan, OE; Ozgen, T1
Oruçkaptan, HH; Ozcan, OE; Ozgen, T; Senmevsim, O1
Delgrange, E; Donckier, J; Guigard, MP; Jan, M; Jouanneau, E; Maiter, D; Perrin, G; Tourniaire, J; Trouillas, J1
Horvath, E; Kovacs, K; Kuroki, T; Lloyd, RV; Scheithauer, BW; Vidal, S1
Cook, DB; Hall, K; Hall, R; McGregor, AM; Scanlon, MF1
MacFarlane, IA; MacKenzie, JM; Petterson, T; Shaw, MD1
Delahunt, JW; Feek, CM; Grebe, SK1
Davis, JR; Heath, DA; Sheppard, MC1
Bevan, JS; Hourihan, M; Peters, JR; Roberts, A; Sussman, J1
Besser, M; Cook, RJ1
Flanigan, S; Jordan, RM; Kohler, PO; Murphy, FY; Vesely, DL1
Horvath, E; Kovacs, KT; Laws, ER; Randall, RV; Scheithauer, BW; Whitaker, MD1
De Gennes, JL; Heshmati, HM; Metzger, J; Schaison-Cusin, M; Scherrer, H; Thibierge, M; Turpin, G1

Reviews

3 review(s) available for bromocriptine and Invasiveness, Neoplasm

ArticleYear
[Invasive giant prolactinoma].
    Acta otorrinolaringologica espanola, 1998, Volume: 49, Issue:2

    Topics: Adult; Bromocriptine; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasms, Second Primary; Pituitary Neoplasms; Prolactinoma; Skull Base Neoplasms

1998
Prolactin secreting pituitary adenomas: analysis of 429 surgically treated patients, effect of adjuvant treatment modalities and review of the literature.
    Acta neurochirurgica, 1999, Volume: 141, Issue:12

    Topics: Bromocriptine; Chemotherapy, Adjuvant; Combined Modality Therapy; Humans; Hypophysectomy; Injections, Intralesional; Neoplasm Invasiveness; Pituitary Irradiation; Pituitary Neoplasms; Prolactinoma; Radiotherapy, Adjuvant; Treatment Outcome

1999
Pituitary adenomas: results of 684 surgically treated patients and review of the literature.
    Surgical neurology, 2000, Volume: 53, Issue:3

    Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Hormones, Ectopic; Humans; Hypophysectomy; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pituitary Gland; Pituitary Irradiation; Pituitary Neoplasms; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome

2000

Other Studies

20 other study(ies) available for bromocriptine and Invasiveness, Neoplasm

ArticleYear
Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
    World neurosurgery, 2021, Volume: 146

    Topics: Acromegaly; Adult; Antineoplastic Agents, Hormonal; Bromocriptine; Chemotherapy, Adjuvant; Female; Growth Hormone-Secreting Pituitary Adenoma; Hormone Antagonists; Humans; Insulin-Like Growth Factor I; Logistic Models; Male; Microsurgery; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neuroendoscopy; Neurosurgical Procedures; Pituitary Neoplasms; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Reoperation; Retrospective Studies; Sex Factors; Sphenoid Sinus; Treatment Failure; Treatment Outcome; Tumor Burden

2021
Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype.
    Aging, 2020, 12-19, Volume: 13, Issue:1

    Topics: Adenoma; Adult; Aged; Bromocriptine; Cell Proliferation; DNA Copy Number Variations; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genomics; Growth Hormone-Secreting Pituitary Adenoma; Humans; Male; Middle Aged; Neoplasm Invasiveness; Oncogene Proteins v-erbB; Organelle Biogenesis; Pituitary Neoplasms; Prognosis; Prolactin; Prolactinoma; Proto-Oncogene Proteins c-myc; Ribosomes; RNA-Seq; Signal Transduction; TOR Serine-Threonine Kinases; Transaminases; Whole Genome Sequencing; Young Adult

2020
Cabergoline for the treatment of bromocriptine-resistant invasive giant prolactinomas.
    Endocrine, 2018, Volume: 62, Issue:2

    Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Drug Resistance, Neoplasm; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Treatment Failure; Tumor Burden; Young Adult

2018
Treatments of multi-invasive giant prolactinoma.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2004, Volume: 11, Issue:1

    Topics: Aged; Bromocriptine; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Microscopy, Electron, Transmission; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiotherapy

2004
Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
    Acta neurochirurgica, 2005, Volume: 147, Issue:7

    Topics: Adult; Aged; Bromocriptine; Dopamine Agonists; Drug Resistance; Female; Humans; Hypophysectomy; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Mitotic Index; Neoplasm Invasiveness; Neoplasm Staging; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sex Factors

2005
Combined treatment of invasive giant prolactinomas.
    Pituitary, 2005, Volume: 8, Issue:1

    Topics: Adolescent; Adult; Bromocriptine; Combined Modality Therapy; Craniotomy; Dopamine Agonists; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Treatment Outcome

2005
Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion.
    Pituitary, 2008, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Bromocriptine; Cavernous Sinus; Chemotherapy, Adjuvant; Dopamine Agonists; Empty Sella Syndrome; Female; Follow-Up Studies; Hernia; Humans; Magnetic Resonance Imaging; Male; Microsurgery; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Optic Chiasm; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiotherapy, Adjuvant; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult

2008
Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
    Obstetrics and gynecology, 1984, Volume: 64, Issue:3 Suppl

    Topics: Adenoma; Adult; Bromocriptine; Female; Hormones; Humans; Neoplasm Invasiveness; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Sella Turcica; Thyrotropin-Releasing Hormone; Tomography, X-Ray Computed

1984
[Effect of treatment with bromocriptine in prolactinomas without surgical intervention].
    Medicina clinica, 1983, Apr-23, Volume: 80, Issue:14

    Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed

1983
[Prolactinoma in man: clinical and histological characteristics].
    Annales d'endocrinologie, 2000, Volume: 61, Issue:3

    Topics: Adolescent; Adult; Bromocriptine; Cell Division; Drug Resistance; Female; Hormone Antagonists; Humans; Ki-67 Antigen; Male; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; Proliferating Cell Nuclear Antigen; Retrospective Studies; Sex Characteristics

2000
Microvessel density in pituitary adenomas and carcinomas.
    Virchows Archiv : an international journal of pathology, 2001, Volume: 438, Issue:6

    Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD34; Antigens, Nuclear; Bromocriptine; Carcinoma; Child; Dopamine Agonists; Female; Hormones; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Male; Microcirculation; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic; Nuclear Proteins; Octreotide; Pituitary Neoplasms

2001
Reduction in size of a pituitary tumor by bromocriptine therapy.
    The New England journal of medicine, 1979, Feb-08, Volume: 300, Issue:6

    Topics: Adenoma; Adult; Bromocriptine; Humans; Male; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed

1979
Prolactin secreting pituitary carcinoma.
    Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:12

    Topics: Adult; Brain; Bromocriptine; Combined Modality Therapy; Humans; Hypophysectomy; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pituitary Irradiation; Pituitary Neoplasms; Prolactin; Prolactinoma

1992
Treatment of extensively invasive (giant) prolactinomas with bromocriptine.
    The New Zealand medical journal, 1992, Apr-08, Volume: 105, Issue:931

    Topics: Adult; Bromocriptine; Humans; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactinoma

1992
Giant invasive prolactinoma: a case report and review of nine further cases.
    The Quarterly journal of medicine, 1990, Volume: 74, Issue:275

    Topics: Adult; Aged; Bromocriptine; Dopamine; Female; Humans; Jugular Veins; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; RNA, Messenger; Tumor Cells, Cultured

1990
Development of an invasive macroprolactinoma: a possible consequence of prolonged oestrogen replacement. Case report.
    British journal of obstetrics and gynaecology, 1989, Volume: 96, Issue:12

    Topics: Adult; Bromocriptine; Estrogen Replacement Therapy; Female; Humans; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactinoma

1989
A 16 year old boy with poor vision and nasal obstruction.
    The Australian and New Zealand journal of surgery, 1987, Volume: 57, Issue:7

    Topics: Adenoma; Adolescent; Bromocriptine; Combined Modality Therapy; Humans; Male; Neoplasm Invasiveness; Nose Diseases; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed; Vision Disorders; Visual Fields

1987
Giant invasive prolactinomas.
    The American journal of medicine, 1987, Volume: 83, Issue:5

    Topics: Adult; Bromocriptine; Cobalt Radioisotopes; Combined Modality Therapy; Ear, Inner; Humans; Male; Middle Aged; Neoplasm Invasiveness; Paranasal Sinuses; Pituitary Gland; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed

1987
Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases.
    Cancer, 1985, Feb-01, Volume: 55, Issue:3

    Topics: Biological Assay; Brain Neoplasms; Bromocriptine; Combined Modality Therapy; Ergolines; Female; Histocytochemistry; Hormones; Humans; Microscopy, Electron; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Pergolide; Pituitary Neoplasms; Prolactin

1985
[Results of bromocriptine treatment of giant or invasive prolactin adenomas. Apropos of 20 cases].
    Annales de medecine interne, 1985, Volume: 136, Issue:6

    Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Time Factors

1985